Author:
Rocca Celine J.,Cherqui Stephanie
Funder
National Institutes of Health
Cystinosis Research Foundation
California Institute for Regenerative Medicine
Publisher
Springer Science and Business Media LLC
Subject
Nephrology,Pediatrics, Perinatology and Child Health
Reference78 articles.
1. Pastores GM, Barnett NL (2005) Current and emerging therapies for the lysosomal storage disorders. Expert Opin Emerg Drugs 10:891–902
2. Hasilik A, Klein U, Waheed A, Strecker G, von Figura K (1980) Phosphorylated oligosaccharides in lysosomal enzymes: identification of alpha-N-acetylglucosamine(1)phospho(6)mannose diester groups. Proc Natl Acad Sci U S A 77:7074–7078
3. Ratko TA, Marbella A, Godfrey S, Aronson N (2013) Enzyme-replacement therapies for lysosomal storage diseases, Rockville, MD. Agency for Healthcare Research and Quality (US); Report No.: 12(13)-EHC154-EF
4. Enns GM, Huhn SL (2008) Central nervous system therapy for lysosomal storage disorders. Neurosurg Focus 24:E12
5. Ruivo R, Anne C, Sagne C, Gasnier B (2009) Molecular and cellular basis of lysosomal transmembrane protein dysfunction. Biochim Biophys Acta 1793:636–649
Cited by
20 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献